Weekly signal · RVMD · Healthcare

Revolution Medicines Inc (RVMD) adds 5.9% as biotech strength holds in weekly context

The oncology drug developer’s 52-week weekly price path remains firm, though the latest turnover came in below its recent average.

Revolution Medicines Inc
Latest162.99 USD
1W move5.9%
Volume0.8x
TrendActive
Weekly market chart context for Revolution Medicines, a biotechnology company focused on oncology therapies.

Market update

What happened

Revolution Medicines Inc (RVMD) rose 5.9% for the week ended June 19, closing at 162.99 USD. The move kept the Nasdaq-listed biotechnology name in an active trend state within a weekly price path over 52 weeks.

The broader setup is still strong but not one-sided. The shares are up 7.5% over four weeks and 76.2% over twelve weeks, while latest weekly volume of 11.6 million shares was below the 13-week average of 15.0 million. Market Dynamics at 0.92 adds confirmation, with Relative Strength at 64.1.

Continue your research

Explore RVMD across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

RVMD coverage

Evidence context